ABSTRACT: Carbohydrate energy intake in excess of total energy expenditure is converted to fat. In fish, the liver is considered to be the main lipogenic tissue. Its regulation by insulin is not fully understood, and some of the available in vivo findings are contradictory. In this study, bovine insulin was infused for 5 d into rainbow trout fed a high-carbohydrate diet, and variables of de novo hepatic lipogenesis were measured. We found that hepatic lipogenesis in trout is stimulated by insulin, reflected in enhanced mRNA and protein abundance and enzyme activity of ATP-citrate lyase, acetyl-CoA carboxylase, and fatty acid synthase. These results were further supported by parallel changes in enzymes acting as NAD phosphate donors, especially those participating in the pentose phosphate pathway. This is the first time that the main enzymes involved in de novo hepatic lipogenesis have been studied at the molecular, protein, and activity levels in fish. We hypothesize that some of the delayed changes found in the different levels of regulation were probably related to the insulin resistance achieved by the trout liver after 5 d of insulin infusion. We assessed enzyme activity and mRNA abundance of lipid oxidation-related enzymes in the livers of insulin-infused fish in which paradoxically increased β-oxidation potential was found. The insulinstimulated de novo hepatic lipogenesis in carbohydratefed trout reinforces the hypothesis that this pathway may act as an important sink for excess glucose, which could ultimately contribute to improved glucose homeostasis in this carnivorous and glucose-intolerant species when fed high-carbohydrate diets.
INTRODUCTION
As in rainbow trout (Oncorhynchus mykiss), de novo hepatic lipogenesis (DNL) in salmonids is regulated by several factors, including nutritional status (Lin et al., 1977a) , energy content in the diet (Kolditz et al., 2008) , genetic background ), antidiabetic drugs Polakof et al., 2011b) , macronutrients (Álvarez et al., 2000) , migration processes (Sheridan et al., 1985) , and hormones (Cowley and Sheridan, 1993; Higgs et al., 2009) .
Insulin stimulates synthesis of fatty acids and triacylglycerols and enhances triacylglycerol storage in the liver through long-term effects on the expression of lipogenic genes, and this is often accompanied by inhibition of fatty acid oxidation in mammals (Kersten, 2001 ). The picture is unclear in fish, where the insulin effects reported are contradictory and the mechanisms of insulin regulation have not been fully elucidated (Machado et al., 1988; Pérez-Sánchez, 1988; PlagnesJuan et al., 2008; Polakof et al., 2009 Polakof et al., , 2010b . Recent findings suggest a major role of DNL in glucose homeostasis, including a better glycemic profile in trout treated with metformin Polakof et al., 2011b) and in genetically selected lines (SkibaCassy et al., 2009) . To obtain greater understanding of the effects of insulin on hepatic DNL under physiological conditions, we infused rainbow trout with insulin for 5 d. Because of the anabolic action of this hormone , we hypothesized that insulin at physiological doses would stimulate DNL to store the excess circulating glucose. We assessed the activity, protein, and mRNA abundance of key enzymes involved in lipogenesis as well as the main enzymes acting as NAD phosphate (NADPH) donors. Tissue insulin sensitivity was estimated on the basis of the phosphorylation status of protein kinase B (Akt/PKB), a critical node in the insulin signaling pathway in fish and mammals (Taniguchi et al., 2006) . Insulinregulated lipid metabolism was examined through measurement of representative lipid oxidation enzymes.
MATERIALS AND METHODS
The experiments were conducted following the Guidelines of the National Legislation on Animal Care of the French Ministry of Research (Decret No. 2001 -464, May 29, 2001 ) and were approved by the Ethics Committee of INRA (according to INRA 2002 -36, April 14, 2002 .
Fish
Rainbow trout (Oncorhynchus mykiss Walbaum) were obtained from the INRA experimental fish farm facilities of Donzacq (Landes, France). Fish were maintained in tanks kept in open recirculated circuits with 17°C well-aerated water and controlled photoperiod [light:dark, 12:12 (h/d)] and fed a standard trout commercial diet during the acclimation period (T-3P classic, Trouw, France; CP = 49.8% DM, crude fat = 13.8% DM; GE = 22 kJ/g of DM). Mean fish BW was 200 ± 10 g.
Experimental Protocols
For sustained hormone infusions, fish were feed-deprived for 48 h and then implanted with 1003D Alzet mini-osmotic pumps (Alzed Osmotic Pumps, Cupertino, CA) containing saline (control, n = 12) or bovine insulin (Sigma Chemical Co., St. Louis, MO) solution (n = 12) at 2 doses. Fish were anesthetized, BW measured, and pumps inserted into the peritoneal cavity through a 1.0-cm incision made in the ventral midline at approximately 2.0 cm rostral of the pelvic fins. The incision was closed with 1 stitch, and an antibiotic gel was applied topically to the incision area. Pumps were implanted in the morning, and fish were allowed to recover for 24 h. Fish were then hand-fed once daily at 2% BW with a diet containing an increased quantity of carbohydrate (30% dextrin, 57% fish meal, and 10% fish oil) for 5 d and sampled 6 h after their last meal. Pump flow rate was established to be 0.39 µL·h −1 , which at 17°C should provide sustained release of 0.35 or 0.7 insulin IU·kg −1 ·d −1 (Ins 0.35 and Ins 0.70, respectively). The doses and heterologous insulin used in the present study were selected on the basis of previous studies (Plisetskaya et al., 1993; Polakof et al., 2009 ).
Tissue and Blood Sampling
Trout were killed by a sharp blow on the head. Blood (approximately 1 mL) was removed from the caudal vessel and centrifuged (3,000 × g, 5 min, 4°C). Plasma was frozen at −20°C pending analyses. The gut contents of each fish were systematically checked to confirm that the fish being sampled had consumed the diet. Livers were collected and frozen in liquid N and stored at −80°C pending analyses, except for 1 piece of each liver that was immediately homogenized to assess carnitine palmitoyltransferase (CPT1) activity (see below).
Molecular and Biochemical Analyses
Plasma glucose (Biomérieux, Marcy l'Etoile, France), triglycerides (Biomérieux), and NEFA (NEFA C from Wako Chemicals GmbH, Neuss, Germany) concentrations were determined using commercial kits adapted to a microplate format (Polakof et al., 2010a,b;  Table 1 ). Bovine insulin concentrations were measured in trout plasma using a bovine-specific commercial ELISA kit (Mercodia, Sweden) according to Polakof et al. (2009) . The intraassay CV was 2.3%, and the interassay CV was 6.7%.
Tissue mRNA abundance encoding proteins involved in lipid and energy metabolism were determined by realtime quantitative reverse-transcription PCR (qPCR; Polakof et al., 2010a) . Total RNA was extracted from livers using TRIzol reagent (Invitrogen, Carlsbad, CA) according to the manufacturer's recommendations. One microgram of the resulting total RNA was reverse transcribed into cDNA using the SuperScript III RNaseH-Reverse Transcriptase kit (Invitrogen) and random primers (Promega, Charbonnières, France) according to the manufacturer's instructions. Real- Within a row, different superscript letters indicate differences between the groups (P < 0.05).
time reverse-transcription PCR was carried out with an iCycler iQ real-time PCR detection system (BioRad, Hercules, CA) using iQ SYBR Green Supermix. Rozen and Skaletsky, 2000) using known sequences found in trout nucleotide databases (GenBank and INRA-Sigenae) as described previously (Ducasse-Cabanot et al., 2007; Polakof et al., 2010a Polakof et al., , 2011a . The transcript of elongation factor 1α (EF1α) was stably expressed in this study. ]. Efficiency of PCR was measured by the slope of a standard curve using serial dilutions of cDNA.
Western blotting (20 µg of protein extracted from the liver) was undertaken using anti-phospho-Akt Ser 473 (Cell Signaling Technology, Ozyme, St Quentin-enYvelines, France), anti-FAS (Santa Cruz Biotechnology, Santa Cruz, CA), anti-ACLY (Cell Signaling Technology), anti-phospho-ACC Ser 79 (Upstate, Euromedex, Munolsheim, France), and anti-β-tubulin (Cell Signaling Technology). All antibodies were raised against human protein, except for Akt/PKB, which was raised against mouse protein. Briefly, frozen livers (300 mg) were homogenized on ice with an UltraTurrax homogenizer in a buffer containing 150 mM NaCl, 10 mM Tris, 1 mM EGTA, 1 mM EDTA (pH 7.4), 100 mM sodium fluoride, 4 mM sodium pyrophosphate, 2 mM sodium orthovanadate, 1% Triton X-100, 0.5% NP-40-IGEPAL, and Complete, Ultra, Mini, EDTA-free, EASYpack Protease Inhibitor Cocktail (Roche, Basel, Switzerland; 1 tablet/5 mL) [4-(2-aminoethyl)-benzenesulfonyl fluoridehydrochloride, polyethylene glycol, polyvinylpyrrolidone, N-α-p-tosyl-l-lysine chloromethyl ketone hydrochloride, benzethonium chloride, dmannitol, phenylmethylsulfonyl fluoride]. Homogenates were centrifuged for 15 min at 12,000 × g, 4°C, and the resulting supernatants stored at −80°C. Protein concentrations were determined using the Bio-Rad protein assay kit (Bio-Rad). Protein lysates (20 µg) were subjected to SDS-PAGE and Western blotting using the appropriate antibody. After washing, membranes were incubated with an IRDye infrared secondary antibody (Li-Cor Biotechnology, Lincoln, NE). Bands were visualized by infrared fluorescence using the Odyssey imaging system (Li-Cor Biotechnology) and quantified by Odyssey infrared imaging system software (version 1.2). The signal of each protein was normalized to the β-tubulin signal. Validation of Akt/PKB and FAS mammalian antibodies was previously demonstrated in the trout Polakof et al., 2010a) . The trout ACLY (GAY7CUQ01A40MK.s.om.10, CA349411.s.om.10) AA sequence is 90% homologous to human ACLY (NP_001087.2), whereas the trout FAS (Sigenae database, GAY7CUQ02F6SW9) AA sequence is 88% homologous to human FAS (NP_004095.4). As in the rat ACC (NP_071529.1), a serine was also found in the trout ACC protein (Sigenae database, FYV3OTN01B4R4N.s.om.10).
Livers used to assess enzyme activities were homogenized with ice-cold buffer [10 (wt/vol); 20 mM Tris, pH 7.4, 250 mM sucrose, 2 mM EDTA, 10 mM β-mercaptoethanol, 100 mM NaF, 0.5 mM EDTA]. The homogenate was centrifuged for 20 min at 17,000 × g, 4°C, and the supernatant was used immediately for enzyme assays. Hydroxyacyl-CoA dehydrogenase (HOAD) and ACC were assessed as in Kolditz et al. (2008) , whereas G6PDH and FAS were assessed following the method described by Figueiredo-Silva et al. (2010) adapted to trout tissues. Enzyme activity of malic enzyme and 6PGDH were assessed as in Mommsen et al. (2003) adapting the substrate liver concentration: 0.5 mM phosphogluconic acid for 6PGDH and 0.08 mM malic acid for malic enzyme. Enzyme activity of ACLY was determined as in Álvarez et al. (2000) . Total CPT1 activity was assessed on fresh tissue as in Gutières et al. (2003) . Enzyme activity is expressed in terms of milligrams of protein. Protein concentrations were determined using a Bradford protein assay kit (Bio-Rad) with BSA as standard (Bradford, 1976) .
Statistical Analysis
Results are expressed as means ± SEM (n = 6). Data were analyzed by 1-way ANOVA. When necessary, data were log-transformed to fulfill the conditions of the ANOVA. Posthoc comparisons were made using a Student-Newman-Keuls test, and differences were considered statistically significant at P < 0.05 (Table 2) .
RESULTS
Plasma glucose concentrations in the group receiving the smaller insulin dose were less (P = 0.029) than in the other 2 groups (control and larger insulin dose), whereas in the larger dose group (P > 0.10) glycemia was similar to the saline-infused group. Plasma triglyceride concentrations were unaffected (P > 0.10) by insulin infusion when compared with the saline-infused group. In contrast, FFA concentrations in plasma were reduced after insulin infusion (P = 0.011 and 0.046, respectively). Bovine insulin concentrations were 2-fold greater in the animals infused with the 0.7 IU·kg The phosphorylation status of liver Akt/PKB Ser473 was unchanged (P > 0.10) by insulin infusion (Figure 1 ). Liver ACLY, ACC, and FAS enzyme activities, protein, and mRNA transcript abundance are shown in Figure  2 . No changes were observed (P > 0.10) in ACLY activity irrespective of the insulin dose. Smaller-dose insulin increased (P = 0.016) ACLY mRNA 2-fold compared with controls. Larger-dose insulin increased (P = 0.033) ACLY protein compared with saline controls. Both protein (P = 0.039) and activity (P = 0.013) of ACC were upregulated in fish receiving 0.7 IU·kg −1 ·d −1 of insulin. No changes (P > 0.10) in ACC mRNA abundance were noted in the control group. The abundance of FAS mRNA were upregulated (P = 0.048) by insulin, only at the 0.35 IU·kg −1 ·d −1 dose. The protein and activity of FAS were unaffected (P > 0.10) by the low dose of insulin treatment and increased (P = 0.034) by the larger-insulin dose.
Changes in enzyme activity and mRNA abundance of proteins acting as NADPH donors in the liver are shown in Figure 3 . Enzyme activity of 6PGDH, G6P-DH, and malic enzyme were increased (6PGDH, P = 0.009; G6PDH, P = 0.001; malic enzyme, P = 0.05) by insulin. Transcript abundance for 6PGDH was upregulated (Ins 0.35, P < 0.001; Ins 0.7, P = 0.009) in a dose-dependent manner.
Changes in activity of enzymes involved in lipid oxidation pathways in the liver are shown in Table 3 . The activity of HOAD was increased in trout infused with the hormone independent of the insulin dose (P = 0.048 for Ins 0.35; P = 0.021 for Ins 0.7), whereas no changes in mRNA abundance were noted (P > 0.10). No changes in CPT1 activity were noted in any of the insulininfused groups (P > 0.10), although mRNA abundance increased with the larger-insulin dose for CPT1A (P = 0.025) and increased with both insulin doses for CPT1B (P = 0.017 for Ins 0.35; P = 0.025 for Ins 0.7).
DISCUSSION

Insulin-Stimulated DNL Potential in Rainbow Trout Liver
Although the role of adipose tissue in DNL remains to be elucidated in fish (Polakof et al., 2011a) , the liver has been traditionally considered to be the main lipogenic organ in many fish species, including salmonids (Henderson and Sargent, 1985) . In the study presented here, we analyzed important enzymes involved in DNL, including ACLY, ACC, and FAS. This is the first global assessment of insulin regulated-DNL in the trout liver to date. ) and then fed for 5 d. Gels were loaded with 20 µg of total protein per lane. Protein and phosphorylation contents were normalized to tissue β-tubulin content and are indicated as fold change compared with the saline-treated group. Results are expressed as means ± SEM (n = 6).
Despite the lack of changes in the relative phosphorylation status of Akt/PKB in our study, significant changes were noted in DNL-related enzymes. The fact that Akt/PKB was unaffected by the insulin infusion 6 h after feeding does not mean that the effects observed here were Akt/PKB-independent because earlier phosphorylation of this protein has been reported in the postprandial state ; Skiba-Cassy et ; Ins 0.35 and Ins 0.7, respectively) and then fed for 5 d. Gene expression was measured by real-time PCR. Expression was normalized to elongation factor 1α (EF1α)-expressed transcripts that did not change under the experimental conditions and are presented as fold change against the Sal solution-treated group set at 1. Enzyme activity is expressed in milli-international units per milligram of protein for ACLY and micro-international units per milligram of protein for ACC and FAS. Protein (20 µg per lane) and phosphorylation content was normalized to tissue β-tubulin content and is indicated as fold change compared with the Sal-treated group. Results are presented as means ± SEM (n = 6). Different letters (a,b) indicate significant differences between the groups (P < 0.05).
al., 2009). It should be borne in mind that, despite the presence of insulin receptors, the liver is not a highly insulin-sensitive tissue Navarro et al., 2006) . We cannot rule out that some degree of insulin resistance may be induced by insulin infusion in this species (Polakof et al., 2010c) or that there is insufficient stimulation of the trout Akt/PKB systyem by heterologous insulin. This may explain the lack of Figure 3 . Effects of insulin infusion on glucose 6-phosphate dehydrogenase (G6PDH), 6-phosphogluconate dehydrogenase (6PGDH), malic enzyme, and isocitrate dehydrogenase (ICDH) enzyme activity and mRNA abundance in livers of trout fed a high-carbohydrate diet. Fish were implanted with pumps containing saline (Sal; control) or 2 insulin doses (0.35 or 0.7 IU·kg -1 ·d −1 ; Ins 0.35 and Ins 0.7, respectively) and then fed for 5 d. Gene expression was measured by real-time PCR. Expression was normalized to elongation factor 1α (EF1α)-expressed transcripts, which did not change under the experimental conditions and are presented as fold-change against the Sal solution-treated group set at 1. Enzyme activity is expressed in milli-international units per milligram of protein. Results are presented as means ± SEM (n = 6). Different letters (a,b) indicate significant differences between the groups (P < 0.05).
hyperglycemia with the larger insulin dose and some of the differences between the molecular and biochemical regulation of the enzymes studied.
The primary enzyme responsible for the synthesis of cytosolic acetyl-CoA is ACLY. Although its activity and gene expression have already been described for fish liver, this is the first time that insulin regulation of the enzyme has been assessed in vivo. We found enhanced ACLY mRNA in fish receiving the decreased insulin dose, whereas protein amounts were upregulated with the greater insulin dose. These differences between mRNA and protein abundance may be due to delayed protein synthesis after increased transcript production, although we cannot eliminate the possibility of an insulin-resistance effect with the greater hormone dose. Further support for this phenomenon could be found in the different regulation of ACLY mRNA abundance (unchanged; Lansard et al., 2010) and activity (increased; Álvarez et al., 2000) in trout hepatocytes stimulated with both insulin and glucose. The lack of changes in activity in the present study may have been due to increased citrate concentrations from the tricarboxylic acid cycle or changes in the phosphorylation status of the protein (Potapova et al., 2000) . Our results also agree with the regulation described for this enzyme in mammals, where ACLY is stimulated in the presence of insulin and glucose (Fukuda and Iritani, 1999) .
The formation of malonyl-CoA, an essential substrate for FAS and fatty acid chain elongation in DNL, is catalyzed by ACC. We observed complex regulation of ACC in the livers of rainbow trout, based on gene expression analysis, protein phosphorylation profiles, and enzyme activity measurements. The findings confirm the presence of a functional ACC in the trout liver, supporting previous studies in which ACC activity was increased in trout fed increased carbohydrate (Rollin et al., 2003) or reduced energy (Kolditz et al., 2008) diets. As stated above, insulin stimulates the hepatic lipogenic pathway in mammals. Whereas no changes in gene expression were noted, both the phosphorylation on the Ser 79 and activity were clearly upregulated in those trout receiving the larger insulin dose. It is possible that a transient increase in ACC transcription occurred over the 5-d infusion period that could account for the increased enzyme activity. Although ACC activity in trout is increased in glucose and insulin-stimulated hepatocytes (Álvarez et al., 2000) , no information is available regarding the phosphoregulation of ACC in fish. In mammals, AMP-kinase phosphorylation of ACC on Ser 79 leads to inhibition of enzyme activity, and insulin-stimulated dephosphorylation of the serine causes an increase in liver ACC activity (Witters and Kemp, 1992) . The fact that in the present study insulin seems to increase ACC activity despite the enhanced phosphorylation status on Ser 79 suggests that the regulation of this enzyme in trout is complex and probably different from the mammalian model.
In mammals and birds, FAS gene expression, protein, and activity are upregulated in the presence of insulin (Griffin and Sul, 2004; Radenne et al., 2008) . We observed that FAS activity is also upregulated by insulin, suggesting that the regulation by both insulin and glucose is similar in the trout to that reported in other vertebrates. These results agree with previous findings obtained in fed trout subjected to similar treatments (Polakof et al., 2011b) . The amount of FAS mRNA (Lansard et al., 2010) and activity (Álvarez et al., 2000) are upregulated in glucose-and insulin-stimulated trout hepatocytes.
Insulin Regulates NAPDH Donors in Rainbow Trout Liver
The DNL in the cytoplasm of vertebrate cells requires a carbon source (acetyl-CoA) and reducing equivalents Table 3 . Hepatic enzyme activity and mRNA abundance of β-oxidation-related enzymes in rainbow trout fed a high-carbohydrate diet and implanted with mini-osmotic pumps infusing saline alone (control) or 2 insulin doses (0.35 or 0.7 IU·kg Within a row, different superscript letters indicate differences between the groups (P < 0.05).
1 HOAD, 3-hydroxyacyl-CoA dehydrogenase; CPT-1, carnitine palmitoyltransferase 1. Enzyme activity units (mIU) are defined as nanomoles of substrate converted to product, per minute, at assay temperature, expressed as milligrams of protein. Expression was normalized to elongation factor 1α (EF1α)-expressed transcripts, which did not change under the experimental conditions and are presented in arbitrary units.
(NADPH) produced by 1 or more of 4 cytoplasmic dehydrogenases (G6PDH, 6PGDH, ICDH, and malic enzyme). All these enzymes have been characterized in the liver of different fish species, including salmonids (Baldwin and Reed, 1976; Walton and Cowey, 1982) . The mRNA and enzyme activity of the 4 NADPH donors in the trout liver were measured. Activity was in the same range as reported by others (Lin et al., 1977b; Kolditz et al., 2008) , with malic enzyme exhibiting the least activity. Insulin enhanced the activity of all the enzymes acting as NADPH donors, except for ICDH, which remained unaffected. The fact that these enzymes are mainly affected at similar activity as the lipogenic ACLY, ACC, and FAS suggests a minor molecular regulation by insulin for these enzymes and confirms the importance of the NADPH donors for DNL in fish liver (Lin et al., 1977b; Aster and Moon, 1981) . The greater activity of G6PDH and 6PGDH compared with malic enzyme also suggest that the major NADPH donors in trout liver are those involved in the pentose phosphate pathway and that insulin acts as a stimulator of such a metabolic route (Novello et al., 1969) .
Paradoxical Regulation of β-Oxidation Potential in Trout Liver by Insulin
A paradoxical imbalance in the regulation of DNL and lipid oxidation pathways seems to exist when insulin is infused. The CPT1 activity remained unchanged and even upregulated at the molecular level, especially with the larger insulin dose. The absence of inhibition of CPT1 activity in our conditions could be due to the presence of long-chain n-3 fatty acids provided by fish oil in the diet. Liver CPT1 activity is increased by n-3 fatty acids in mammals (Ide et al., 2000) . Surprisingly, we also found increased HOAD activity in fed fish infused with insulin. It was previously reported that increased glucose concentrations in fish, both in vivo (intraperitoneal injection; Harmon et al., 1991) and in vitro (Harmon and Sheridan, 1992) , stimulate lipolysis rates through increased hepatic lipase activity. Moreover, in mammals increased HOAD activity was found in sand rats (Psammomys obesus) subjected to hyperglycemia and hyperinsulinemia (Nakai et al., 1997) . We therefore suggest that β-oxidation in trout liver is highly influenced by diet composition (increased amounts of fish oil and carbohydrates), which could act as the major regulator of CPT1 and HOAD activity, irrespective of the insulin dose.
Conclusions and Perspective
Our findings indicate that DNL in rainbow trout is regulated by insulin, which increases the 3 major enzymes involved in this pathway at molecular, protein, and enzyme activity. This is further supported by the concomitant upregulation of some enzymes acting as NADPH donors, especially those participating in the pentose phosphate pathway. The fact that insulin also stimulates this pathway in high carbohydrate-fed rats (Nepokroeff et al., 1974) and in hyperinsulinemic patients fed low-fat/high-carbohydrate diets (Schwarz et al., 2003) supports the idea of a strongly conserved regulatory role of insulin in hepatic DNL. On the other hand, although some studies in the 1970 to 1980s were contradictory concerning the role of insulin in highcarbohydrate-fed catfish (Warman and Bottino, 1978; Machado et al., 1988) , later studies in vitro confirmed that insulin stimulates DNL in trout (Cowley and Sheridan, 1993) . This is relevant in carnivorous fish species fed high-carbohydrate diets because their natural carbohydrate intake is about 1%. Despite this apparent paradox, the incorporation of the excess glucose from the diet into hepatic lipogenesis seems to be a common feature in this species (Hung and Storebakken, 1994) . In our study, part of the hypoglycemia observed in fish infused with the smaller insulin dose (data not shown) could then be due to this increased DNL potential.
